Skip to main content
. 2021 Nov 30;28(4):317–323. doi: 10.11005/jbm.2021.28.4.317

Fig. 2.

Fig. 2

Bone mineral density (BMD) percentage mean change at 6 months after treatment with romosozumab and at 12 months after treatment with denosumab or ibandronate. Error bars represent the 95% confidence interval of the mean.